LLGL1 Regulates Gemcitabine Resistance by Modulating the ERK-SP1-OSMR Pathway in Pancreatic Ductal Adenocarcinoma

BACKGROUND & AIMS: Gemcitabine resistance is rapidly acquired by pancreatic ductal adenocarcinoma (PDAC) patients. Novel approaches that predict the gemcitabine response of patients and enhance gemcitabine chemosensitivity are important to improve patient survival. We aimed to identify genes as...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Yin-Xin, Li, Chi Han, Li, Guolin, Feng, Huiyi, Xia, Tian, Wong, Chi Hin, Fung, Frederic Khe Cheong, Tong, Joanna Hung-Man, To, Ka-Fai, Chen, Rufu, Chen, Yangchao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505810/
https://www.ncbi.nlm.nih.gov/pubmed/32615164
http://dx.doi.org/10.1016/j.jcmgh.2020.06.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505810/
https://www.ncbi.nlm.nih.gov/pubmed/32615164
http://dx.doi.org/10.1016/j.jcmgh.2020.06.009

Ejemplares similares